USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress
- PMID: 32968046
- PMCID: PMC7511960
- DOI: 10.1038/s41419-020-03008-5
USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress
Abstract
Chemotherapy remains an essential part of diverse treatment regimens against human malignancies. However, recent progressions have revealed a paradoxical role of chemotherapies to induce the cancer stem cell-like features that facilitate chemoresistance and tumor dissemination, with the underlying mechanisms underinvestigated. The zinc-finger transcription factor Snail1 is a central regulator during the epithelial-mesenchymal transition process and is closely implicated in cancer progression. Snail1 expression is strictly regulated at multiple layers, with its stability governed by post-translational ubiquitylation that is counterbalanced by the activities of diverse E3 ligases and deubiquitylases. Here we identify the deubiquitylase USP29 as a novel stabilizer of Snail1, which potently restricts its ubiquitylation in a catalytic activity-dependent manner. Bioinformatic analysis reveals a reverse correlation between USP29 expression and prognosis in lung adenocarcinoma patients. USP29 is unique among Snail1 deubiquitylases through exhibiting chemotherapy-induced upregulation. Mechanistically, oxidative stresses incurred by chemotherapy stimulate transcriptional activation of USP29. USP29 upregulation enhances the cancer stem cell-like characteristics in lung adenocarcinoma cells to promote tumorigenesis in athymic nude mice. Our findings uncover a novel mechanism by which chemotherapy induces cancer stemness and suggest USP29 as a potential therapeutic target to impede the development of chemoresistance and metastasis in lung adenocarcinoma.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Deubiquitinase USP29 promotes gastric cancer cell migration by cooperating with phosphatase SCP1 to stabilize Snail protein.Oncogene. 2020 Oct;39(44):6802-6815. doi: 10.1038/s41388-020-01471-0. Epub 2020 Sep 24. Oncogene. 2020. PMID: 32973332
-
TGFβ-Activated USP27X Deubiquitinase Regulates Cell Migration and Chemoresistance via Stabilization of Snail1.Cancer Res. 2019 Jan 1;79(1):33-46. doi: 10.1158/0008-5472.CAN-18-0753. Epub 2018 Oct 19. Cancer Res. 2019. PMID: 30341066 Free PMC article.
-
Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.Cancer Lett. 2018 Apr 1;418:135-146. doi: 10.1016/j.canlet.2018.01.030. Epub 2018 Jan 11. Cancer Lett. 2018. PMID: 29331415 Free PMC article.
-
The emerging role of Snail1 in the tumor stroma.Clin Transl Oncol. 2016 Sep;18(9):872-7. doi: 10.1007/s12094-015-1474-9. Epub 2015 Dec 21. Clin Transl Oncol. 2016. PMID: 26687368 Review.
-
The emerging role of USP29 in cancer and other diseases.Cell Biochem Funct. 2024 Jan;42(1):e3928. doi: 10.1002/cbf.3928. Cell Biochem Funct. 2024. PMID: 38269503 Review.
Cited by
-
Ubiquitin-specific Protease 35 Promotes Gastric Cancer Metastasis by Increasing the Stability of Snail1.Int J Biol Sci. 2024 Jan 12;20(3):953-967. doi: 10.7150/ijbs.87176. eCollection 2024. Int J Biol Sci. 2024. PMID: 38250150 Free PMC article.
-
USP29 activation mediated by FUBP1 promotes AURKB stability and oncogenic functions in gastric cancer.Cancer Cell Int. 2024 Jan 17;24(1):33. doi: 10.1186/s12935-024-03224-5. Cancer Cell Int. 2024. PMID: 38233848 Free PMC article.
-
Metabolic Adaptation and Cellular Stress Response As Targets for Cancer Therapy.World J Mens Health. 2024 Jan;42(1):62-70. doi: 10.5534/wjmh.230153. World J Mens Health. 2024. PMID: 38171377 Free PMC article. Review.
-
USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and cancer cell survival upon ribotoxic stress.Nat Commun. 2023 Oct 13;14(1):6473. doi: 10.1038/s41467-023-42257-8. Nat Commun. 2023. PMID: 37833415 Free PMC article.
-
Survivin degradation by bergenin overcomes pemetrexed resistance.Cell Oncol (Dordr). 2023 Dec;46(6):1837-1853. doi: 10.1007/s13402-023-00850-5. Epub 2023 Aug 5. Cell Oncol (Dordr). 2023. PMID: 37542022
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
